CHANGES IN THE PHARMACOKINETICS OF CIPROFLOXACIN AND FECAL FLORA DURING ADMINISTRATION OF A 7-DAY COURSE TO HUMAN VOLUNTEERS

被引:155
作者
BRUMFITT, W
FRANKLIN, I
GRADY, D
HAMILTONMILLER, JMT
ILIFFE, A
机构
关键词
D O I
10.1128/AAC.26.5.757
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
引用
收藏
页码:757 / 761
页数:5
相关论文
共 12 条
[1]   THE PHARMACOKINETICS AND TISSUE PENETRATION OF NORFLOXACIN [J].
ADHAMI, ZN ;
WISE, R ;
WESTON, D ;
CRUMP, B .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1984, 13 (01) :87-92
[2]   RIFAPRIM (RIFAMPICIN PLUS TRIMETHOPRIM) - PHARMACOKINETICS AND EFFECTS ON THE NORMAL FLORA OF MAN [J].
BRUMFITT, W ;
HAMILTONMILLER, JMT .
BIOPHARMACEUTICS & DRUG DISPOSITION, 1981, 2 (02) :157-166
[3]  
BRUMFITT W, 1962, LANCET, V1, P130
[4]  
Cowan ST., 1974, COWAN STEELS MANUAL, V2, P67
[5]   TRANSPORT AND STORAGE OF FAECES FOR BACTERIOLOGICAL EXAMINATION [J].
CROWTHER, JS .
JOURNAL OF APPLIED BACTERIOLOGY, 1971, 34 (02) :477-+
[6]   PHARMACOKINETICS AND TISSUE PENETRATION OF CIPROFLOXACIN [J].
CRUMP, B ;
WISE, R ;
DENT, J .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 24 (05) :784-786
[7]   INVITRO ACTIVITY OF CIPROFLOXACIN (BAY O 9867) [J].
FASS, RJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 24 (04) :568-574
[8]   TOXIGENICITY AND ANTI-MICROBIAL SUSCEPTIBILITY OF CLOSTRIDIUM-DIFFICILE, A CAUSE OF ANTI-MICROBIAL AGENT ASSOCIATED COLITIS [J].
GEORGE, WL ;
SUTTER, VL ;
FINEGOLD, SM .
CURRENT MICROBIOLOGY, 1978, 1 (01) :55-58
[9]   ABSORPTION, DISTRIBUTION, METABOLIC-FATE, AND ELIMINATION OF PEFLOXACIN MESYLATE IN MICE, RATS, DOGS, MONKEYS, AND HUMANS [J].
MONTAY, G ;
GOUEFFON, Y ;
ROQUET, F .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 25 (04) :463-472
[10]   INVITRO STUDIES WITH CIPROFLOXACIN, A NEW 4-QUINOLONE COMPOUND [J].
REEVES, DS ;
BYWATER, MJ ;
HOLT, HA ;
WHITE, LO .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1984, 13 (04) :333-346